VRTXのPER（株価収益率）は？

VERTEX PHARMACEUTICALS INC（VRTX）は現在PER 28.18倍で取引されています。

VRTXのROE（自己資本利益率）は？

VERTEX PHARMACEUTICALS INCのROEは22.41%です。

VRTXの配当利回りは？

VERTEX PHARMACEUTICALS INCの配当利回りは0.00%です。

VRTXの品質スコア（Quality Score）は？

当社のAIはVRTXの総合財務品質を100点中77点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

VRTXは今が買い時ですか？

当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

VRTXはどのセクターに属しますか？

VERTEX PHARMACEUTICALS INCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

VRTX (NASDAQ) 株価分析 | VERTEX PHARMACEUTICALS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

VRTX AI Analysis Summary

Our AI summary for VRTX: VERTEX PHARMACEUTICALS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 28.18, ROE of 22.41%, a dividend yield of 0.00%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

VRTX

VERTEX PHARMACEUTICALS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 477.10

-4.60 (-0.95%) Day Change

Watchlist Portfolio Compare Chart

28.18

P/E

0.37

D/E

22.4%

ROE

16.4%

ROA

0.00%

Div Yield

-0.09

PEG

VERTEX PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 477.10 Price -4.60 (-0.95%) Day Change	NEWS SCORE: 99

VRTX, ファンダメンタルスコアはgood ( ファンダメンタル = 77) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

77 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: ROEの伸びが低い
ROAの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...

Deepscope 分析

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	970
Magic Formula Rank by ROE	970
Magic Formula Rank by ROIC	1126
Price	477.10
PBV / Sector	6.31 / 5.20
Earning Per Share	16.93

PE / Sector	28.18 / 19.97
PEG or PE/Growth / Sector	-0.09 / 1.22
Average 1M Daily Value	694.51 M
Average 1W Daily Value	639.57 M

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

54%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

72%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	35.40 / 98.71 GREAT
NPM Average (%) / Sector	27.43 / -1,721.76 GREAT
NPM Change Average (%) / Sector	-220.04 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	16.38 / 27.02 GOOD
ROA Average (%) / Sector	12.67 / -368.17
ROA Change Average (%) / Sector	-213.94 / 5,404.12
ROE (%) / Sector	22.41 / 3.47 GOOD
ROE Average (%) / Sector	16.96 / 6.51
ROE Change Average (%) / Sector	-218.18 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:40
Symbol	VRTX
Name	VERTEX PHARMACEUTICALS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	253.81 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	122,258.08 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 50 Northern Avenue, Boston, MA, United States, 02210

Phone: 617 341 6100

Website: https://www.vrtx.com

Employees: 6,400

Sector: Healthcare >> Biotechnology

Description: Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of SCD and TDT; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease, which is in single Phase 2 trial; VX-264 for treating Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. The company sells its products primarily to specialty pharmacy and distributors, wholesalers, retail pharmacies, hospitals, and clinics. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.